Shanghai GenTech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	3.4yrs
Board average tenure	5.5yrs

Recent management updates

Recent updates

Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues

Nov 06

Shanghai GenTech Co., Ltd. (SHSE:688596) Stock Rockets 28% But Many Are Still Ignoring The Company

Oct 01

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Mar 03

CEO

Shanghai GenTech has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Hong Liang Zheng	CFO & Deputy GM	3.4yrs	CN¥1.85m	0.51% CN¥ 52.4m
Yue Chen	Deputy GM & Secretary	3.4yrs	CN¥1.82m	1.03% CN¥ 105.2m
Kecheng Shi	General Manager	3yrs	CN¥2.72m	0.77% CN¥ 78.6m

3.4yrs

Average Tenure

50yo

Average Age

Experienced Management: 688596's management team is considered experienced (3.4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Zhong Xin Fei	Independent Director	5.5yrs	CN¥120.00k	no data
Haiwen Xie	Director	4.7yrs	no data	no data
Yong Huang	Director	8.4yrs	CN¥1.22m	9.34% CN¥ 951.0m
Mingzheng Zhou	Chairman of the Board of Supervisors	3.4yrs	no data	no data
Feng Yu	Supervisor	8.5yrs	no data	0.50% CN¥ 51.2m
Rong Cui	Director	15.8yrs	CN¥1.82m	no data
Dong Lei Yu	Chairman	9.4yrs	CN¥2.11m	no data
Wenyan Hu	Independent Director	3.4yrs	CN¥120.00k	no data
Yue Liu	Independent Director	2.2yrs	CN¥120.00k	no data

5.5yrs

Average Tenure

54yo

Average Age

Experienced Board: 688596's board of directors are considered experienced (5.5 years average tenure).

Shanghai GenTech Management

Management criteria checks 2/4

Key information

Recent management updates

Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Recent updates

Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues

Third quarter 2024 earnings released: EPS: CN¥0.80 (vs CN¥0.45 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

Shanghai GenTech Co., Ltd. (SHSE:688596) Stock Rockets 28% But Many Are Still Ignoring The Company

Shanghai GenTech Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 19%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.29 (vs CN¥0.53 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Does Shanghai GenTech (SHSE:688596) Have A Healthy Balance Sheet?

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

Shanghai GenTech Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Sentiment Still Eluding Shanghai GenTech Co., Ltd. (SHSE:688596)

Price target decreased by 9.8% to CN¥46.00

Do Shanghai GenTech's (SHSE:688596) Earnings Warrant Your Attention?

New minor risk - Dividend sustainability

Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.04 in 1Q 2023)

Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Shanghai GenTech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Returns On Capital At Shanghai GenTech (SHSE:688596) Have Stalled

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Full year 2023 earnings: EPS exceeds analyst expectations

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.33 in 3Q 2022)

Price target decreased by 9.4% to CN¥52.00

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.19 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022)

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 12% to CN¥50.50

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 120 million worth of its shares.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.07 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.48 (vs CN¥0.45 in FY 2019)

New 90-day low: CN¥15.90

Investor sentiment deteriorated over the past week

New 90-day low: CN¥18.86

New 90-day low: CN¥20.75

Shanghai GenTech Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

First half earnings released

CEO

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age